Impact of combining cognitive intervention and psychological care on the mental health of patients with benign breast tumors
Abstract
To explore the effect of cognitive intervention combined with psychological nursing on the mental health of female patients undergoing surgery for benign breast tumors. From September 2023 to September 2024, 80 patients with benign breast tumors who underwent surgery in our hospital were selected as study subjects and randomly divided into a control group and a study group using a random number table, with 40 patients in each group. The control group received routine nursing, while the study group received cognitive intervention combined with psychological nursing on the basis of the control group. The mental status, coping styles, and illness uncertainty of the two groups were observed and compared. After nursing, the self-rating anxiety scale (SAS) and self-rating depression scale (SDS) scores of the study group were lower than those of the control group (p < 0.05). In terms of coping styles, the simplified coping style questionnaire (SCSQ) positive coping score of the study group was significantly higher than that of the control group (p < 0.05), while the negative coping score of the study group was significantly lower than that of the control group (p < 0.05). Additionally, in terms of illness uncertainty, the study group had lower scores than the control group on the Mishel Uncertainty in Illness Scale Adult (MUISA) for uncertainty, complexity, lack of information, and unpredictability (p < 0.05). Implementing cognitive intervention combined with psychological nursing for female patients undergoing surgery for benign breast tumors can significantly improve their mental health, reduce their uncertainty during treatment, and prompt them to actively cope with the disease. There are also some limitations in this study. Firstly, the sample size of the study is small; secondly, the patients included in this study were benign tumor patients, so the requirements of the intervention technique do not need to be very high, which may also affect the results of the experiment.
Copyright (c) 2025 Feifei Xu, Sheng Xu
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. L W, T G. Understanding breast cancer as a global health concern. The British journal of radiology. 2022;95. doi:10.1259/bjr.20211033
2. C K, I O, Hk K, S S. Breast cancer: Presentation, investigation and management. British journal of hospital medicine (London, England : 2005). 2022;83. doi:10.12968/hmed.2021.0459
3. ZHENG Ying WC. The epidemic and characteristics of female breast cancer in China. China Oncology. 2014;23: 561–569. doi:10.3969/j.issn.1007-3969.2013.08.001
4. Steven,A. N, Javaid I, Anthony B M. Why have breast cancer mortality rates declined? Journal of Cancer Policy. 2015;5: 8–17. doi:10.1016/j.jcpo.2015.03.002
5. D D, J F, Rd E, L K-G, M S, V A. Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic. International journal of cancer. 2025;156. doi:10.1002/ijc.35204
6. N R, Dg H, M H, Pv L, A N, Pe B, et al. Depressive symptom trajectories in women affected by breast cancer and their male partners: A nationwide prospective cohort study. Journal of cancer survivorship : research and practice. 2016;10. doi:10.1007/s11764-016-0538-3
7. P H, G S, J M, J H, Jm B. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: Results from the UK standardisation of radiotherapy trials (START). Breast (Edinburgh, Scotland). 2010;19. doi:10.1016/j.breast.2009.11.007
8. Sw M, C R, Aj B, Pf V, Gh de B. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas. 2015;82. doi:10.1016/j.maturitas.2015.04.010
9. Ciria-Suarez L, Jiménez-Fonseca P, Palacín-Lois M, Antoñanzas-Basa M, Fernández-Montes A, Manzano-Fernández A, et al. Breast cancer patient experiences through a journey map: A qualitative study. PLoS One. 2021;16: e0257680. doi:10.1371/journal.pone.0257680
10. Ms M-R, S H, I A, B de V, A R-L, T R, et al. One-year quality of life outcomes of delayed unilateral autologous breast reconstruction and associated patient factors. JPRAS open. 2024;43. doi:10.1016/j.jpra.2024.10.014
11. Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10: 51–61. doi:10.1007/s11764-015-0450-2
12. Sa R, H P, D S, Sc T, Es Z, A W, et al. Incidence of patient-reported fatigue developing on palbociclib and endocrine therapy for advanced HR+ HER2- breast cancer. The oncologist. 2024 [cited 21 Dec 2024]. doi:10.1093/oncolo/oyae316
13. Me S, J C-C, A V, J H, D F-J, K S. Fatigue and quality of life in breast cancer survivors: Temporal courses and long-term pattern. Journal of cancer survivorship : research and practice. 2012;6. doi:10.1007/s11764-011-0197-3
14. Je B, Pa G, Ka D, C B, Jh R, Be M, et al. Fatigue in long-term breast carcinoma survivors: A longitudinal investigation. Cancer. 2006;106. doi:10.1002/cncr.21671
15. Hjg A, Mfm G, Ic S, Cahhvm V, Mm R, H K. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: A meta-analysis involving 12 327 breast cancer survivors. Annals of oncology : official journal of the European Society for Medical Oncology. 2016;27. doi:10.1093/annonc/mdw099
16. C VO, Ba C, K L, L D, Be A, C W, et al. Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012;20. doi:10.1007/s00520-012-1381-3
17. K D, Jj M, I S, A D, Q L, Sx X, et al. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2013;21. doi:10.1007/s00520-012-1490-z
18. B R, Jl K. Benign breast diseases: Epidemiology, evaluation, and management. Clinical obstetrics and gynecology. 2011;54. doi:10.1097/GRF.0b013e318208010e
19. C F, H B, F A, J H, J D, D P. Risk factors for benign proliferative breast disease. International journal of epidemiology. 2000;29. doi:10.1093/ije/29.4.637
20. L W-J, S G, Hl M. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology. 2007;32. doi:10.1016/j.psyneuen.2006.09.011
21. Af van der S, Cm K-D, J DV, Ja R. Effect of abnormal screening mammogram on quality of life. The British journal of surgery. 2011;98. doi:10.1002/bjs.7371
22. Ma A, Js C, Jl S, Mj C, Ll C, A B, et al. Psychological impact of benign breast biopsy: A longitudinal, comparative study. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2002;21. Available: https://pubmed.ncbi.nlm.nih.gov/12211516/
23. Z W, X H. Clinical significance of breast-conserving surgery for early breast cancer and its impact on patient life quality of life. Journal of BUON : official journal of the Balkan Union of Oncology. 2019;24. Available: https://pubmed.ncbi.nlm.nih.gov/31786853/
24. Cc R, S P, F W, Wf C, Rs V. The lived experience during the peri-diagnostic period of breast cancer: A scoping review. Patient education and counseling. 2022;105. doi:10.1016/j.pec.2021.06.017
25. Pa P, F A, B F, Dl U, Y L, Ja K, et al. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: A 2-year prospective study. European urology. 2013;63. doi:10.1016/j.eururo.2013.01.034
26. Eg E, Ah P, Pk H, N van D-B, F C, E M, et al. Disclosing the uncertainty associated with prognostic estimates in breast cancer. Medical decision making : an international journal of the Society for Medical Decision Making. 2017;37. doi:10.1177/0272989X16670639
27. Mn L, Mf C, Sc C, Pl C. Uncertainty and anxiety during the diagnostic period for women with suspected breast cancer. Cancer nursing. 2008;31. doi:10.1097/01.NCC.0000305744.64452.fe
28. Ll N, T T, D M, M O. Couples’ adjustment to breast cancer and benign breast disease: A longitudinal analysis. Psycho-oncology. 1998;7. doi:10.1002/(SICI)1099-1611(199801/02)7:1<37::AID-PON314>3.0.CO;2-#
29. H Z, L W, X Y, Sw C, Y G, X L, et al. Effects of decisional conflict, decision regret and self-stigma on quality of life for breast cancer survivors: A cross-sectional, multisite study in China. Journal of advanced nursing. 2022;78. doi:10.1111/jan.15250
30. Y Z, K K, M P. Uncertainty, self-efficacy, and self-care behavior in patients with breast cancer undergoing chemotherapy in China. Cancer nursing. 2015;38. doi:10.1097/NCC.0000000000000165
31. Mf C, Mh M, M B. Testing a model of symptoms, communication, uncertainty, and well-being, in older breast cancer survivors. Research in nursing & health. 2006;29. doi:10.1002/nur.20108
32. Rs L. Coping theory and research: Past, present, and future. Psychosomatic medicine. 1993;55. doi:10.1097/00006842-199305000-00002
33. Leger KA, Charles ST, Turiano NA, Almeida DM. Personality and stressor-related affect. Journal of Personality and Social Psychology. 2016;111: 917–928. doi:10.1037/pspp0000083
34. Patricia A. Ganz MD. Psychological and social aspects of breast cancer. 2008;22. Available: https://www.cancernetwork.com/view/psychological-and-social-aspects-breast-cancer
35. Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Deutsches Ärzteblatt International. 2019;116: 565. doi:10.3238/arztebl.2019.0565
36. Huang J, Chan PS, Lok V, Chen X, Ding H, Jin Y, et al. Global incidence and mortality of breast cancer: A trend analysis. Aging (Albany NY). 2021;13: 5748. doi:10.18632/aging.202502
37. Jm D, V D, J L, Js W, U C. Assessment of the acceptability of conservative management of fibroadenoma of the breast. The British journal of surgery. 1996;83. Available: https://pubmed.ncbi.nlm.nih.gov/8689184/
38. Feten Fekih-Romdhane MD, Fatma Saadallah MD, Mahdi Mbarek MD, Hatem Bouzaiene MD, Majda Cheour MD. Prevalence and correlates of hopelessness in tunisian women with benign breast disease and breast cancer. Journal of Psychosocial Oncology. 2022 [cited 29 Nov 2024]. Available: https://www.tandfonline.com/doi/abs/10.1080/07347332.2021.1943103
39. Broadbridge E, Greene K, Venetis MK, Lee LE, Banerjee SC, Saraiya B, et al. Facilitating psychological adjustment for breast cancer patients through empathic communication and uncertainty reduction. Patient education and counseling. 2023;114: 107791. doi:10.1016/j.pec.2023.107791
40. Ms Y, H L, Ja Y. [effects of a cognitive-behavioral nursing intervention on anxiety and depression in women with breast cancer undergoing radiotherapy]. Journal of Korean Academy of Nursing. 2009;39. doi:10.4040/jkan.2009.39.2.157
41. N H, T K, Ib C, S S, S D, F L, et al. Integrated moving on after breast cancer and culturally adapted cognitive behavior therapy intervention for depression and anxiety among pakistani women with breast cancer: Protocol of a randomized controlled trial. SAGE open medicine. 2023;11. doi:10.1177/20503121231177549
42. I S-B, Ø E, R K. Variability and stability of coping styles among breast cancer survivors: A prospective study. Psycho-oncology. 2021;30. doi:10.1002/pon.5587
43. Km G, Mh M, M B, B G, Ls P, M C. Benefits of the uncertainty management intervention for african American and white older breast cancer survivors: 20-month outcomes. International journal of behavioral medicine. 2006;13. doi:10.1207/s15327558ijbm1304_3
